Perminder Pam Mangat

Aug 26 2019 - 2:43pm

TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations.

Aug 19 2019 - 11:30am

TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations.

 

Aug 19 2019 - 11:27am

Case reports and small prospective trials suggest that administering targeted therapies to patients with advanced cancer and an identified genomic target may be associated with clinical benefit.